Important point there is an option to cut short phases with agreement to FDA, looks like IMU is looking at these options and they are excited about it, thats a huge news I would say, if a clinical stage biotech thinks at this level, we have a huge winner here.. IMU is excited we are also excited...
Media Thread, page-6407
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(1.04%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $482.4K | 10.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 33 | 1611621 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2348545 | 19 |
View Market Depth
| Last trade - 12.36pm 10/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |